A liposomal RNA vaccine inducing neoantigen-specific CD4


Journal

Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526

Informations de publication

Date de publication:
22 06 2020
Historique:
entrez: 14 9 2020
pubmed: 15 9 2020
medline: 15 9 2020
Statut: epublish

Résumé

Antigen-encoding, lipoplex-formulated RNA (RNA-LPX) enables systemic delivery to lymphoid compartments and selective expression in resident antigen-presenting cells. We report here that the rejection of CT26 tumors, mediated by local radiotherapy (LRT), is further augmented in a CD8

Identifiants

pubmed: 32923128
doi: 10.1080/2162402X.2020.1771925
pii: 1771925
pmc: PMC7458669
doi:

Substances chimiques

Antigens, Neoplasm 0
Cancer Vaccines 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1771925

Informations de copyright

© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Références

Nature. 2020 Sep;585(7823):107-112
pubmed: 32728218
Immunity. 2017 Nov 21;47(5):848-861.e5
pubmed: 29126798
Oncotarget. 2016 Jul 12;7(28):43039-43051
pubmed: 27343548
Blood. 2003 Aug 15;102(4):1449-57
pubmed: 12714523
BMC Genomics. 2014 Mar 13;15:190
pubmed: 24621249
Annu Rev Immunol. 2019 Apr 26;37:173-200
pubmed: 30550719
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Nat Methods. 2015 May;12(5):380-1
pubmed: 25924071
Hum Genomics. 2005 Jun;2(2):138-43
pubmed: 16004729
Nat Med. 2005 Oct;11(10):1113-7
pubmed: 16186817
J Immunol. 2012 Jul 15;189(2):558-66
pubmed: 22685313
J Exp Med. 2010 Mar 15;207(3):637-50
pubmed: 20156971
Immunity. 2014 Nov 20;41(5):843-52
pubmed: 25517616
Nat Rev Cancer. 2018 May;18(5):313-322
pubmed: 29449659
Mol Ther. 2019 Apr 10;27(4):824-836
pubmed: 30638957
Immunotherapy. 2015;7(8):847-9
pubmed: 26268988
Cancer Res. 2010 Nov 15;70(22):9031-40
pubmed: 21045153
Immunity. 2000 Oct;13(4):529-38
pubmed: 11070171
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Methods Mol Biol. 2017;1499:223-236
pubmed: 27987153
Cancer Res. 2016 Oct 15;76(20):5994-6005
pubmed: 27550452
J Virol. 2014 Jan;88(1):314-24
pubmed: 24155379
Gene Ther. 2010 Aug;17(8):961-71
pubmed: 20410931
Nat Rev Immunol. 2017 Feb;17(2):97-111
pubmed: 27748397
PLoS Comput Biol. 2015 Nov 25;11(11):e1004503
pubmed: 26606115
Nat Med. 2018 Dec;24(12):1845-1851
pubmed: 30397353
Clin Cancer Res. 2017 Sep 15;23(18):5514-5526
pubmed: 28533222
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
J Immunol. 2008 Jan 1;180(1):309-18
pubmed: 18097032
Cancer Res. 2017 Feb 15;77(4):839-850
pubmed: 27821490
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):879-80
pubmed: 23078897
J Clin Invest. 2014 Feb;124(2):687-95
pubmed: 24382348
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
Oncoimmunology. 2018 Dec 24;8(3):1553478
pubmed: 30723585
Cancer Res. 2010 Apr 1;70(7):2697-706
pubmed: 20215523
Cancer Immunol Immunother. 2007 Oct;56(10):1577-87
pubmed: 17361438
Mol Cancer Ther. 2015 Jun;14(6):1336-45
pubmed: 25833837
Blood. 2006 Dec 15;108(13):4009-17
pubmed: 16940422
Nature. 2015 Apr 16;520(7547):373-7
pubmed: 25754329
Cancer Immunol Res. 2014 Feb;2(2):91-8
pubmed: 24778273
Radiat Environ Biophys. 2014 Mar;53(1):1-29
pubmed: 24141602
Nature. 2015 Apr 30;520(7549):692-6
pubmed: 25901682
Blood. 2009 Jul 16;114(3):589-95
pubmed: 19349616
Radiat Oncol. 2014 Aug 15;9:180
pubmed: 25127546
Cancer Res. 2004 Jun 15;64(12):4328-37
pubmed: 15205348
Cancer Res. 2014 Oct 1;74(19):5458-68
pubmed: 25274032
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9730-5
pubmed: 8790399
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Annu Rev Med. 2019 Jan 27;70:395-407
pubmed: 30691374
Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1188-95
pubmed: 24661671
Oncoimmunology. 2019 Jul 11;8(9):e1629259
pubmed: 31428528
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
J Exp Med. 2006 May 15;203(5):1259-71
pubmed: 16636135
J Immunol. 2005 Jun 15;174(12):7516-23
pubmed: 15944250
Immunol Rev. 2017 Nov;280(1):249-279
pubmed: 29027221

Auteurs

Nadja Salomon (N)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Fulvia Vascotto (F)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Abderaouf Selmi (A)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Mathias Vormehr (M)

BioNTech SE, 55131 Mainz, Germany.

Juliane Quinkhardt (J)

BioNTech SE, 55131 Mainz, Germany.

Thomas Bukur (T)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Barbara Schrörs (B)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Martin Löewer (M)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Mustafa Diken (M)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Özlem Türeci (Ö)

BioNTech SE, 55131 Mainz, Germany.

Ugur Sahin (U)

BioNTech SE, 55131 Mainz, Germany.
Research Center for Immunotherapy (FZI) of the University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Sebastian Kreiter (S)

TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH